Functional MRI for Urinary Incontinence
Trial Summary
Will I have to stop taking my current medications?
If you are currently using anticholinergic or beta-3 agonist medications, you will need to stop taking them for at least 4 weeks before participating in the study. For other medications, the protocol does not specify, but any expected changes in medication during the study may affect eligibility.
What data supports the effectiveness of the treatment Brain functional MRI with simplified urodynamics for urinary incontinence?
The research shows that functional MRI can map brain activity related to bladder control and pelvic floor muscle contractions, which are important for managing urinary incontinence. This suggests that understanding brain responses during bladder control could help improve treatments for urinary incontinence.12345
Is functional MRI for urinary incontinence safe for humans?
How does this treatment for urinary incontinence differ from other treatments?
This treatment uses functional MRI (fMRI) to study brain activity related to bladder control, which is unique because it focuses on understanding the brain's role in urinary incontinence rather than directly treating the bladder or pelvic muscles. This approach could lead to new insights and therapies by targeting the brain's involvement in bladder function.12358
What is the purpose of this trial?
Urge urinary incontinence (UUI) is a common problem in older people which vastly reduces quality of life, yet the cause and mechanism of disease are not well understood. This study will characterize brain control of the bladder in young and old continent individuals and age-matched incontinent counterparts. This will expand the investigators current knowledge of how the brain controls the bladder, how that control changes with age and disease, and suggest new targets to guide development of better treatment.
Research Team
Becky Clarkson, PhD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for women aged 18-45 or 65+ with urge urinary incontinence (UUI) more than five times a week, despite treatment. It's also for continent women without UUI. Participants must be able to differentiate between UUI and stress incontinence, have no major health issues affecting mobility or requiring upcoming surgery, and be MRI compatible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Neuroimaging Evaluation
Participants undergo detailed neuroimaging to evaluate brain structures and functions related to bladder control
Data Analysis
Analysis of neuroimaging data to compare brain structure and function across different groups
Follow-up
Participants are monitored for any changes in brain function or urinary continence
Treatment Details
Interventions
- Brain functional MRI with simplified urodynamics
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute on Aging (NIA)
Collaborator